NAS:INGN (USA)
Business Description
Inogen Inc
NAICS : 325412
SIC : 3842
301 Coromar Drive, Goleta, CA, USA, 93117
Description
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.88 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 4.1 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 5.16 | |||||
| Beneish M-Score | -2.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -14.3 | |||||
| 3-Year Book Growth Rate | 4.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.38 | |||||
| 9-Day RSI | 72.4 | |||||
| 14-Day RSI | 67.35 | |||||
| 6-1 Month Momentum % | -9.89 | |||||
| 12-1 Month Momentum % | -53.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.32 | |||||
| Quick Ratio | 4.75 | |||||
| Cash Ratio | 3.77 | |||||
| Days Inventory | 62.28 | |||||
| Days Sales Outstanding | 32.95 | |||||
| Days Payable | 28.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.43 | |||||
| Operating Margin % | -4.74 | |||||
| Net Margin % | -8.03 | |||||
| ROE % | -7.68 | |||||
| ROA % | -5.8 | |||||
| ROIC % | -12.37 | |||||
| ROC (Joel Greenblatt) % | -18.22 | |||||
| ROCE % | -3.91 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 58.03 | |||||
| PS Ratio | 2.04 | |||||
| PB Ratio | 2.03 | |||||
| Price-to-Tangible-Book | 2.71 | |||||
| EV-to-EBIT | -31.72 | |||||
| EV-to-EBITDA | 86.62 | |||||
| EV-to-Revenue | 1.49 | |||||
| EV-to-FCF | -16.46 | |||||
| Price-to-Projected-FCF | 1.37 | |||||
| Price-to-Net-Current-Asset-Value | 3.6 | |||||
| Price-to-Net-Cash | 6.61 | |||||
| Earnings Yield (Greenblatt) % | -3.15 | |||||
| Forward Rate of Return (Yacktman) % | -23.96 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:INGN
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 353.269 | ||
| EPS (TTM) ($) | -1.25 | ||
| Beta | 0.68 | ||
| Volatility % | 54.89 | ||
| 14-Day RSI | 67.35 | ||
| 14-Day ATR ($) | 1.396267 | ||
| 20-Day SMA ($) | 28.151 | ||
| 12-1 Month Momentum % | -53.82 | ||
| 52-Week Range ($) | 22.51 - 63.61 | ||
| Shares Outstanding (Mil) | 22.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inogen Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||